Is the maximum tolerated dose (MDT) still the optimal goal for cancer drugs? (ABC6)


E-session 592012

Expert
Larry Norton'
Memorial Sloan-Kettering Cancer Center
New York, USA

This e-Session is part of the following pathway(s):
01
Nov 2021

Material selected from